on 30 Apr 2019
Last Applicant/ Owned by
4130 Parklake Avenue, Suite 400
Raleigh
US
27612
Serial Number
86887877 filed on 27th Jan 2016
Registration Number
5740079 registered on 30th Apr 2019
Correspondent Address
ROBIN C. VANCEMCGUIREWOOS LLP
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceutical research services, namely, clinical research and development; medical and scientific research, namely, conducting clinical trials, medical research, research in the field of biotechnology pharmaceutical research services, medical monitoring, pharmacovigilance in the nature of detection, assessment, and prevention of adverse effects of drugs and other drug-related problems, statisticRead More
Regulatory affairs consulting services, namely, regulatory compliance consulting in the field of pharmaceutical development
16th Mar 2016
16th Mar 2016
Pharmaceutical research services, namely, clinical research and development; medical and scientific research, namely, conducting clinical trials, medical research, research in the field of biotechnology pharmaceutical research services, medical monitoring, pharmacovigilance in the nature of detection, assessment, and prevention of adverse effects of drugs and other drug-related problems, statistical analysis, medical writing, and drug logistics, all in the field of clinical research; maintenance of databases for others; providing the services of data management, namely, data compiling, analyzing and tracking in the field of clinical trials for research purposes
16th Mar 2016
16th Mar 2016
Resourcing services for data management, namely, data processing in the nature of the collection, organization, management, analysis and reporting of data gathered in connection with the conduct of a clinical research trial; resourcing services for biostatistics consulting, namely, consulting related to the collection, summarization, and analysis of statistical information from clinical research trials and the interpretation of, and inference from, the results of such trials for use in the biomedical and pharmaceutical industries for business or commercial purposes; providing resources for technical consulting services and information management services, namely, clinical data and regulatory submission management to medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; providing the services of project management, namely, business project management in the field of clinical trials; providing resources for the services of site management, namely, identifying, qualifying, and selecting sites for clinical trials, negotiating clinical trial site contracts and budgets, organizing and conducting business meetings of clinical trial investigators, assisting investigators with developing business strategies for recruiting clinical trial participants, submitting clinical trial protocols to institutional review boards and independent ethics committees, and business management services in the nature of monitoring clinical trial investigators' activities for compliance with clinical protocols and regulations and for patient safety; providing resources for the services of vendor management to medical, pharmaceutical, biopharmaceutical and biotechnology companies, namely, selecting and managing third-party providers of services that support clinical trials
16th Mar 2016
16th Mar 2016
No 86887877
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
30th Apr 2024 | COURTESY REMINER - SEC. 8 (6-YR) E-MAILE |
14th Jul 2021 | ASSIGNMENT O OWNERSHIP NOT UPATE AUTOMATICALLY |
30th Apr 2019 | REGISTERE-PRINCIPAL REGISTER |
28th Mar 2019 | NOTICE O ACCEPTANCE O STATEMENT O USE E-MAILE |
27th Mar 2019 | ALLOWE PRINCIPAL REGISTER - SOU ACCEPTE |
26th Mar 2019 | NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE |
23rd Mar 2019 | STATEMENT O USE PROCESSING COMPLETE |
23rd Mar 2019 | SOU EXTENSION 5 GRANTE |
23rd Mar 2019 | CASE ASSIGNE TO INTENT TO USE PARALEGAL |
06th Mar 2019 | USE AMENMENT ILE |